# Engaging Home-monitored Assessment to Navigate Clinical Decision-making

Study · id `cardio:ct-nct07399912` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07399912](<https://clinicaltrials.gov/study/NCT07399912>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07399912

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 116 participants.

## Technical summary

Registry record NCT07399912. Randomized; single masking; primary purpose health services research. Start 2025-10-01 (actual); primary completion 2026-10-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose health services research
- Phase: Not applicable
- Enrolled: 116 participants (planned count; ClinicalTrials.gov record NCT07399912, source copy `cardio:ctgov-nct07399912-2026-02-10`, retrieved 2026-10-26)
- Started: 2025-10-01 (actual) (ClinicalTrials.gov record NCT07399912, source copy `cardio:ctgov-nct07399912-2026-02-10`, retrieved 2026-10-26)
- Primary completion: 2026-10-01 (anticipated) (ClinicalTrials.gov record NCT07399912, source copy `cardio:ctgov-nct07399912-2026-02-10`, retrieved 2026-10-26)
- Completion: 2026-10-01 (anticipated) (ClinicalTrials.gov record NCT07399912, source copy `cardio:ctgov-nct07399912-2026-02-10`, retrieved 2026-10-26)
- Countries: Singapore (ClinicalTrials.gov record NCT07399912, source copy `cardio:ctgov-nct07399912-2026-02-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07399912-2026-02-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Engaging Home-monitored Assessment to Navigate Clinical Decision-making
- Acronym: ENHANCe
- Condition: Hypertension,Essential
- Intervention (Device): ENHANCe app
- Intervention (Other): Teaching and training
- Intervention (Other): Usual care
- Lead sponsor: SingHealth Polyclinics
- Lead sponsor class: OTHER
- Collaborator: Nanyang Polytechnic
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: SingHealth Polyclinics (`cardio:org-singhealth-polyclinics`)

## Provenance

Content hash: 5587862611240b7ab1535f2a5a90f2136bcd8aed7017805790bd832e67ca8292
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
